CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Sold out
In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.
- Q2 2022: Stock CYTOKINETICS INC; Country of operation —; Class NOTE 4.000%11/1; Principal before $57,931,000.
- Q2 2022: Stock LYFT INC; Country of operation —; Class NOTE 1.500% 5/1; Principal before $104,468,000.
- Q2 2022: Stock ZILLOW GROUP INC; Country of operation —; Class NOTE 1.375% 9/0; Principal before $82,750,000.
- Q2 2022: Stock ZILLOW GROUP INC; Country of operation —; Class NOTE 0.750% 9/0; Principal before $74,182,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Principal before | Principal after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2022 | CYTOKINETICS INC
CUSIP 23282WAA8 | — | NOTE 4.000%11/1 | $57,931,000 | $0 | -57,931,000 | $212,120 | $0 | -$212,120 | 2022-08-15 |
|---|
| Q2 2022 | LYFT INC
CUSIP 55087PAB0 | — | NOTE 1.500% 5/1 | $104,468,000 | $0 | -104,468,000 | $129,957 | $0 | -$129,957 | 2022-08-15 |
|---|
| Q2 2022 | ZILLOW GROUP INC
CUSIP 98954MAG6 | — | NOTE 1.375% 9/0 | $82,750,000 | $0 | -82,750,000 | $109,786 | $0 | -$109,786 | 2022-08-15 |
|---|
| Q2 2022 | ZILLOW GROUP INC
CUSIP 98954MAE1 | — | NOTE 0.750% 9/0 | $74,182,000 | $0 | -74,182,000 | $94,833 | $0 | -$94,833 | 2022-08-15 |
|---|
| Q2 2022 | EQT CORP
CUSIP 26884LAK5 | — | NOTE 1.750% 5/0 | $33,500,000 | $0 | -33,500,000 | $79,562 | $0 | -$79,562 | 2022-08-15 |
|---|
| Q2 2022 | EXACT SCIENCES CORP
CUSIP 30063PAC9 | — | NOTE 0.375% 3/0 | $82,950,000 | $0 | -82,950,000 | $73,499 | $0 | -$73,499 | 2022-08-15 |
|---|
| Q2 2022 | NCL CORP LTD
CUSIP 62886HAX9 | — | NOTE 5.375% 8/0 | $48,576,000 | $0 | -48,576,000 | $70,538 | $0 | -$70,538 | 2022-08-15 |
|---|
| Q2 2022 | LIVEPERSON INC
CUSIP 538146AB7 | — | NOTE 0.750% 3/0 | $69,585,000 | $0 | -69,585,000 | $69,771 | $0 | -$69,771 | 2022-08-15 |
|---|
| Q2 2022 | BLOOMIN BRANDS INC
CUSIP 094235AB4 | — | NOTE 5.000% 5/0 | $30,000,000 | $0 | -30,000,000 | $60,459 | $0 | -$60,459 | 2022-08-15 |
|---|
| Q2 2022 | OMNICELL COM
CUSIP 68213NAD1 | — | NOTE 0.250% 9/1 | $40,300,000 | $0 | -40,300,000 | $57,036 | $0 | -$57,036 | 2022-08-15 |
|---|
| Q2 2022 | SNAP INC
CUSIP 83304AAD8 | — | NOTE 0.250% 5/0 | $29,979,000 | $0 | -29,979,000 | $53,635 | $0 | -$53,635 | 2022-08-15 |
|---|
| Q2 2022 | CUTERA INC
CUSIP 232109AB4 | — | NOTE 2.250% 3/1 | $21,250,000 | $0 | -21,250,000 | $46,189 | $0 | -$46,189 | 2022-08-15 |
|---|
| Q2 2022 | ARCH RESOURCES INC
CUSIP 039389AB7 | — | NOTE 5.250%11/1 | $10,250,000 | $0 | -10,250,000 | $38,870 | $0 | -$38,870 | 2022-08-15 |
|---|
| Q2 2022 | LIVE NATION ENTERTAINMENT IN
CUSIP 538034AQ2 | — | NOTE 2.500% 3/1 | $21,000,000 | $0 | -21,000,000 | $37,125 | $0 | -$37,125 | 2022-08-15 |
|---|
| Q2 2022 | FARFETCH LTD
CUSIP 30744WAD9 | — | NOTE 3.750% 5/0 | $27,215,000 | $0 | -27,215,000 | $35,363 | $0 | -$35,363 | 2022-08-15 |
|---|
| Q2 2022 | MERCADOLIBRE INC
CUSIP 58733RAD4 | — | NOTE 2.000% 8/1 | $11,393,000 | $0 | -11,393,000 | $31,538 | $0 | -$31,538 | 2022-08-15 |
|---|
| Q2 2022 | THE REALREAL INC
CUSIP 88339PAB7 | — | NOTE 3.000% 6/1 | $35,140,000 | $0 | -35,140,000 | $29,910 | $0 | -$29,910 | 2022-08-15 |
|---|
| Q2 2022 | Q2 HLDGS INC
CUSIP 74736LAD1 | — | NOTE 0.750% 6/0 | $26,405,000 | $0 | -26,405,000 | $26,433 | $0 | -$26,433 | 2022-08-15 |
|---|
| Q2 2022 | BANDWIDTH INC
CUSIP 05988JAB9 | — | NOTE 0.250% 3/0 | $33,495,000 | $0 | -33,495,000 | $25,706 | $0 | -$25,706 | 2022-08-15 |
|---|
| Q2 2022 | OKTA INC
CUSIP 679295AD7 | — | NOTE 0.125% 9/0 | $23,000,000 | $0 | -23,000,000 | $24,739 | $0 | -$24,739 | 2022-08-15 |
|---|
| Q2 2022 | VARONIS SYS INC
CUSIP 922280AB8 | — | NOTE 1.250% 8/1 | $14,000,000 | $0 | -14,000,000 | $23,371 | $0 | -$23,371 | 2022-08-15 |
|---|
| Q2 2022 | REVANCE THERAPEUTICS INC
CUSIP 761330AB5 | — | NOTE 1.750% 2/1 | $23,546,000 | $0 | -23,546,000 | $22,500 | $0 | -$22,500 | 2022-08-15 |
|---|
| Q2 2022 | TRAVERE THERAPEUTICS INC
CUSIP 89422GAA5 | — | NOTE 2.250% 3/0 | $20,000,000 | $0 | -20,000,000 | $21,278 | $0 | -$21,278 | 2022-08-15 |
|---|
| Q2 2022 | HEALTH CATALYST INC
CUSIP 42225TAB3 | — | NOTE 2.500% 4/1 | $18,332,000 | $0 | -18,332,000 | $20,784 | $0 | -$20,784 | 2022-08-15 |
|---|
| Q2 2022 | PEGASYSTEMS INC
CUSIP 705573AB9 | — | NOTE 0.750% 3/0 | $21,000,000 | $0 | -21,000,000 | $19,803 | $0 | -$19,803 | 2022-08-15 |
|---|
| Q2 2022 | NCL CORP LTD
CUSIP 62886HAT8 | — | NOTE 6.000% 5/1 | $11,000,000 | $0 | -11,000,000 | $19,548 | $0 | -$19,548 | 2022-08-15 |
|---|
| Q2 2022 | SAREPTA THERAPEUTICS INC
CUSIP 803607AB6 | — | DBCV 1.500%11/1 | $14,747,000 | $0 | -14,747,000 | $19,372 | $0 | -$19,372 | 2022-08-15 |
|---|
| Q2 2022 | EXACT SCIENCES CORP
CUSIP 30063PAB1 | — | NOTE 0.375% 3/1 | $12,300,000 | $0 | -12,300,000 | $11,631 | $0 | -$11,631 | 2022-08-15 |
|---|
| Q2 2022 | FLUIDIGM CORPORATION
CUSIP 34385PAF5 | — | NOTE 5.250%12/0 | $8,147,000 | $0 | -8,147,000 | $11,174 | $0 | -$11,174 | 2022-08-15 |
|---|
| Q2 2022 | CARNIVAL CORP
CUSIP 143658BE1 | — | NOTE 5.750% 4/0 | $5,000,000 | $0 | -5,000,000 | $10,494 | $0 | -$10,494 | 2022-08-15 |
|---|
| Q2 2022 | MICROSTRATEGY INC
CUSIP 594972AC5 | — | NOTE 0.750%12/1 | $7,500,000 | $0 | -7,500,000 | $10,456 | $0 | -$10,456 | 2022-08-15 |
|---|
| Q2 2022 | LIVE NATION ENTERTAINMENT IN
CUSIP 538034AU3 | — | NOTE 2.000% 2/1 | $8,000,000 | $0 | -8,000,000 | $10,366 | $0 | -$10,366 | 2022-08-15 |
|---|
| Q2 2022 | BILIBILI INC
CUSIP 090040AD8 | — | NOTE 1.250% 6/1 | $8,443,000 | $0 | -8,443,000 | $8,634 | $0 | -$8,634 | 2022-08-15 |
|---|
| Q2 2022 | GOSSAMER BIO INC
CUSIP 38341PAA0 | — | NOTE 5.000% 6/0 | $8,200,000 | $0 | -8,200,000 | $6,691 | $0 | -$6,691 | 2022-08-15 |
|---|
| Q2 2022 | EXACT SCIENCES CORP
CUSIP 30063PAA3 | — | NOTE 1.000% 1/1 | $5,000,000 | $0 | -5,000,000 | $6,011 | $0 | -$6,011 | 2022-08-15 |
|---|
| Q2 2022 | ENVISTA HOLDINGS CORPORATION
CUSIP 29415FAB0 | — | NOTE 2.375% 6/0 | $2,250,000 | $0 | -2,250,000 | $5,334 | $0 | -$5,334 | 2022-08-15 |
|---|
| Q2 2022 | TRAVERE THERAPEUTICS INC
CUSIP 761299AB2 | — | NOTE 2.500% 9/1 | $5,000,000 | $0 | -5,000,000 | $5,222 | $0 | -$5,222 | 2022-08-15 |
|---|
| Q2 2022 | SEA LTD
CUSIP 81141RAD2 | — | NOTE 1.000%12/0 | $2,000,000 | $0 | -2,000,000 | $4,776 | $0 | -$4,776 | 2022-08-15 |
|---|
| Q2 2022 | SABRE GLBL INC
CUSIP 78573NAE2 | — | NOTE 4.000% 4/1 | $2,500,000 | $0 | -2,500,000 | $4,120 | $0 | -$4,120 | 2022-08-15 |
|---|
| Q2 2022 | GRANITE CONSTR INC
CUSIP 387328AB3 | — | NOTE 2.750%11/0 | $2,500,000 | $0 | -2,500,000 | $2,984 | $0 | -$2,984 | 2022-08-15 |
|---|
| Q2 2022 | LOGAN RIDGE FINANCE CORP
CUSIP 14054R403 | — | 5.75% NT CV 22 | $25,400 | $0 | -25,400 | $26 | $0 | -$26 | 2022-08-15 |
|---|